Nirmatrelvir/ ritonavir

DRUG2 trials

Sponsors

Pfizer

Conditions

Biological AvailabilityHealthy Participants

Phase 1

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

CompletedNCT05525910

PfizerBiological Availability, Healthy Participants

Start: 2022-08-31End: 2022-11-07Updated: 2024-09-19

Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.

CompletedNCT05544786

PfizerBiological Availability

Start: 2022-09-28End: 2022-11-29Updated: 2024-05-10